Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY21 results · Jan–Mar 2021
Amrutanjan Health Care reported revenue from operations of ₹94.02 crore (up 58.6% from Q4 FY20) and net profit of ₹10.23 crore (up 29.6% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 94.02 | 59.29 | +58.6% | 100.10 | −6.1% |
| Other income | 2.68 | 2.64 | +1.5% | 2.54 | +5.4% |
| Total income | 96.70 | 61.93 | +56.1% | 102.64 | −5.8% |
| Profit before tax | 13.71 | 10.64 | +28.9% | 28.14 | −51.3% |
| Net profit for the period | 10.23 | 7.89 | +29.6% | 20.99 | −51.3% |
| EPS, basic (₹) | 3.50 | 2.70 | +29.6% | 7.18 | −51.3% |
| Net margin (%) | 10.9 | 13.3 | 21.0 |
Standalone
- Filed with BSE
- 28 May 2021, 09:55 IST
- Board meeting
- 27 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE